Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose (Q40833405)

24 September 2017

title

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose (English)

1 reference

adaptive radiation therapy

24 September 2017

main subject

0 references

postoperative radiation therapy

1 reference

Valicenti RK

1

1 reference

24 September 2017

Gomella LG

2

1 reference

24 September 2017

Ismail M

3

1 reference

24 September 2017

Mulholland SG

4

1 reference

24 September 2017

Strup S

5

1 reference

24 September 2017

Petersen RO

6

1 reference

24 September 2017

Corn BW

7

1 reference

24 September 2017

Lu JD

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

52

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1034-1040

1 reference

Positive surgical margins at radical prostatectomy: importance of the apical dissection.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900405-1

7 January 2021

10.1016/S0090-4295(98)00405-1

Identifiers

DOI

1 reference

24 September 2017

1 reference